(Q39410610)

11 September 2017

1 reference

title

The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

11 September 2017

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Khean-Lee Goh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Masahide Hamaguchi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Seung Up Kim

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Chun-Jen Liu

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Yen-Hsuan Ni

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

18

Grace Lai-Hung Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

19

Henry Lik-Yuen Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

3

Shiv Chitturi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

7

Jiangao Fan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Wah-Kheong Chan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Yogesh Chawla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Yock Young Dan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Ajay Duseja

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Etsuko Hashimoto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Laurentius Adrianto Lesmana

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Yu-Cheng Lin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jose Sollano

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Simon Kin-Hung Wong

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Geoff Farrell

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

3 July 2017

1 reference

Journal of Gastroenterology and Hepatology

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

70-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

Grading quality of evidence and strength of recommendations

2 June 2020

cites work

1 reference

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

21 January 2018

1 reference

NAFLD in Asia--as common and important as in the West

21 January 2018

1 reference

Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.

21 January 2018

1 reference

Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.

21 January 2018

1 reference

Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan

21 January 2018

1 reference

Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey

21 January 2018

1 reference

The relationship between fatty liver and hyperinsulinemia in obese Japanese children.

21 January 2018

1 reference

SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease

21 January 2018

1 reference

Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels

21 January 2018

1 reference

Prevalence of fatty liver in children and adolescents.

21 January 2018

1 reference

Liver steatosis in Polish children assessed by medicolegal autopsies

21 January 2018

1 reference

Obese children with steatohepatitis can develop cirrhosis in childhood

21 January 2018

1 reference

The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study

21 January 2018

1 reference

21 January 2018

Aging and liver disease

1 reference

Non alcoholic fatty liver disease: a clinical approach and review

21 January 2018

1 reference

Nonalcoholic fatty liver disease.

21 January 2018

1 reference

Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue.

21 January 2018

1 reference

Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome

21 January 2018

1 reference

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis

21 January 2018

1 reference

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.

21 January 2018

1 reference

Review article: the metabolic syndrome and non-alcoholic fatty liver disease

21 January 2018

1 reference

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines

21 January 2018

1 reference

Asian consensus on the relationship between obesity and gastrointestinal and liver diseases

21 January 2018

1 reference

Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies

21 January 2018

1 reference

Fatty liver and nonalcoholic steatohepatitis

21 January 2018

1 reference

A concise review of non-alcoholic fatty liver disease

21 January 2018

1 reference

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up

21 January 2018

1 reference

The impact of weight changes on nonalcoholic Fatty liver disease in adult men with normal weight

21 January 2018

1 reference

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

21 January 2018

1 reference

Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease

21 January 2018

1 reference

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

21 January 2018

1 reference

Characteristics and diagnosis of NAFLD/NASH.

21 January 2018

1 reference

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan

21 January 2018

1 reference

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

21 January 2018

1 reference

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

21 January 2018

1 reference

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

21 January 2018

1 reference

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.

21 January 2018

1 reference

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

21 January 2018

1 reference

21 January 2018

1 reference

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

21 January 2018

1 reference

Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

21 January 2018

1 reference

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

21 January 2018

1 reference

Liver cancer in Malaysia: epidemiology and clinical presentation in a multiracial Asian population

21 January 2018

1 reference

Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.

21 January 2018

1 reference

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

21 January 2018

1 reference

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

21 January 2018

1 reference

Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease

21 January 2018

1 reference

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

21 January 2018

1 reference

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.

21 January 2018

1 reference

Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery

21 January 2018

1 reference

Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.

21 January 2018

1 reference

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?

21 January 2018

1 reference

Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Nonalcoholic steatohepatitis: definition and pathology

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.

21 January 2018

1 reference

Pathological features of fatty liver disease

21 January 2018

1 reference

The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH.

21 January 2018

1 reference

Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

21 January 2018

1 reference

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

21 January 2018

1 reference

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.

21 January 2018

1 reference

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

21 January 2018

1 reference

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

21 January 2018

1 reference

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

21 January 2018

1 reference

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

21 January 2018

1 reference

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

21 January 2018

1 reference

Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population

21 January 2018

1 reference

Transient elastography: Kill two birds with one stone?

21 January 2018

1 reference

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy

21 January 2018

1 reference

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

21 January 2018

1 reference

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers

21 January 2018

1 reference

Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis

21 January 2018

1 reference

An apoptosis panel for nonalcoholic steatohepatitis diagnosis

21 January 2018

1 reference

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

21 January 2018

1 reference

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Biomarkers in nonalcoholic fatty liver disease

21 January 2018

1 reference

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

The functions of animal microRNAs

21 January 2018

1 reference

Role of MicroRNAs in NAFLD/NASH.

21 January 2018

1 reference

The lipid-droplet proteome reveals that droplets are a protein-storage depot.

21 January 2018

1 reference

Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications

21 January 2018

1 reference

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

21 January 2018

1 reference

Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives

21 January 2018

1 reference

Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population

21 January 2018

1 reference

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

21 January 2018

1 reference

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients

21 January 2018

1 reference

Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments

21 January 2018

1 reference

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography

21 January 2018

1 reference

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

21 January 2018

1 reference

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

21 January 2018

1 reference

Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease.

21 January 2018

1 reference

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis.

21 January 2018

1 reference

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

21 January 2018

1 reference

Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.

21 January 2018

1 reference

Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

21 January 2018

1 reference

Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling

21 January 2018

1 reference

Bi-directional analysis between fatty liver and cardiovascular disease risk factors

21 January 2018

1 reference

Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults

21 January 2018

1 reference

Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study

21 January 2018

1 reference

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.

21 January 2018

1 reference

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

21 January 2018

1 reference

Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup

21 January 2018

1 reference

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

21 January 2018

1 reference

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis

21 January 2018

1 reference

Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.

21 January 2018

1 reference

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans

21 January 2018

1 reference

Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study

21 January 2018

1 reference

Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006.

21 January 2018

1 reference

Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.

21 January 2018

1 reference

Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy

21 January 2018

1 reference

Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study

21 January 2018

1 reference

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.

21 January 2018

1 reference

Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis

21 January 2018

1 reference

Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

21 January 2018

1 reference

Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese.

21 January 2018

1 reference

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

21 January 2018

1 reference

Variants in the autophagy-related gene IRGM confer susceptibility to non-alcoholic fatty liver disease by modulating lipophagy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.13857

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28670712%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference